Generation Bio Co. Statistics
Total Valuation
GBIO has a market cap or net worth of $28.67 million. The enterprise value is -$63.00 million.
Important Dates
The last earnings date was Thursday, March 13, 2025, after market close.
Earnings Date | Mar 13, 2025 |
Ex-Dividend Date | n/a |
Share Statistics
GBIO has 67.01 million shares outstanding. The number of shares has increased by 3.32% in one year.
Current Share Class | 67.01M |
Shares Outstanding | 67.01M |
Shares Change (YoY) | +3.32% |
Shares Change (QoQ) | +0.08% |
Owned by Insiders (%) | 6.10% |
Owned by Institutions (%) | 69.09% |
Float | 48.78M |
Valuation Ratios
PE Ratio | n/a |
Forward PE | n/a |
PS Ratio | 1.43 |
Forward PS | 5.06 |
PB Ratio | 0.33 |
P/TBV Ratio | 0.33 |
P/FCF Ratio | n/a |
P/OCF Ratio | n/a |
PEG Ratio | n/a |
Financial Ratio History Enterprise Valuation
EV / Earnings | n/a |
EV / Sales | n/a |
EV / EBITDA | n/a |
EV / EBIT | n/a |
EV / FCF | n/a |
Financial Position
The company has a current ratio of 5.50, with a Debt / Equity ratio of 1.09.
Current Ratio | 5.50 |
Quick Ratio | 5.33 |
Debt / Equity | 1.09 |
Debt / EBITDA | n/a |
Debt / FCF | n/a |
Interest Coverage | n/a |
Financial Efficiency
Return on equity (ROE) is -91.02% and return on invested capital (ROIC) is -20.59%.
Return on Equity (ROE) | -91.02% |
Return on Assets (ROA) | -16.34% |
Return on Invested Capital (ROIC) | -20.59% |
Return on Capital Employed (ROCE) | -40.38% |
Revenue Per Employee | $172,974 |
Profits Per Employee | -$1.14M |
Employee Count | 115 |
Asset Turnover | 0.07 |
Inventory Turnover | n/a |
Taxes
Income Tax | n/a |
Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -88.44% in the last 52 weeks. The beta is 2.72, so GBIO's price volatility has been higher than the market average.
Beta (5Y) | 2.72 |
52-Week Price Change | -88.44% |
50-Day Moving Average | 0.66 |
200-Day Moving Average | 1.81 |
Relative Strength Index (RSI) | 29.11 |
Average Volume (20 Days) | 451,568 |
Short Selling Information
The latest short interest is 1.68 million, so 2.51% of the outstanding shares have been sold short.
Short Interest | 1.68M |
Short Previous Month | 2.56M |
Short % of Shares Out | 2.51% |
Short % of Float | 3.44% |
Short Ratio (days to cover) | 4.00 |
Income Statement
In the last 12 months, GBIO had revenue of $19.89 million and -$131.67 million in losses. Loss per share was -$1.98.
Revenue | 19.89M |
Gross Profit | -27.88M |
Operating Income | -79.19M |
Pretax Income | -158.43M |
Net Income | -131.67M |
EBITDA | -74.26M |
EBIT | -79.19M |
Loss Per Share | -$1.98 |
Full Income Statement Balance Sheet
The company has $185.22 million in cash and $93.56 million in debt, giving a net cash position of $91.66 million or $1.37 per share.
Cash & Cash Equivalents | 185.22M |
Total Debt | 93.56M |
Net Cash | 91.66M |
Net Cash Per Share | $1.37 |
Equity (Book Value) | 86.20M |
Book Value Per Share | 1.29 |
Working Capital | 157.85M |
Full Balance Sheet Cash Flow
In the last 12 months, operating cash flow was -$88.56 million and capital expenditures -$2.40 million, giving a free cash flow of -$90.96 million.
Operating Cash Flow | -88.56M |
Capital Expenditures | -2.40M |
Free Cash Flow | -90.96M |
FCF Per Share | -$1.36 |
Full Cash Flow Statement Margins
Gross Margin | -140.16% |
Operating Margin | -398.11% |
Pretax Margin | -661.91% |
Profit Margin | n/a |
EBITDA Margin | n/a |
EBIT Margin | n/a |
FCF Margin | n/a |
Dividends & Yields
GBIO does not appear to pay any dividends at this time.
Dividend Per Share | n/a |
Dividend Yield | n/a |
Dividend Growth (YoY) | n/a |
Years of Dividend Growth | n/a |
Payout Ratio | n/a |
Buyback Yield | -3.32% |
Shareholder Yield | n/a |
Earnings Yield | -459.32% |
FCF Yield | -317.32% |
Analyst Forecast
The average price target for GBIO is $7.33, which is 1,613.42% higher than the current price. The consensus rating is "Strong Buy".
Price Target | $7.33 |
Price Target Difference | 1,613.42% |
Analyst Consensus | Strong Buy |
Analyst Count | 4 |
Revenue Growth Forecast (5Y) | 3.53% |
EPS Growth Forecast (5Y) | -18.66% |
Stock Forecasts Stock Splits
This stock does not have any record of stock splits.
Last Split Date | n/a |
Split Type | n/a |
Split Ratio | n/a |
Scores
GBIO has an Altman Z-Score of -3.79 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
Altman Z-Score | -3.79 |
Piotroski F-Score | 3 |